Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.17B |
| Enterprise value | 1.83B |
| Trailing P/E | 22.44 |
| Forward P/E | 22.32 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.57 |
| Price/book (mrq) | 5.32 |
| Enterprise value/revenue | 4.80 |
| Enterprise value/EBITDA | 13.56 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.54 |
| 52-week change 3 | -2.51% |
| S&P500 52-week change 3 | -1.04% |
| 52-week high 3 | 25.68 |
| 52-week low 3 | 15.83 |
| 50-day moving average 3 | 22.15 |
| 200-day moving average 3 | 20.95 |
Share statistics
| Avg vol (3-month) 3 | 966.41k |
| Avg vol (10-day) 3 | 721.94k |
| Shares outstanding 5 | 106.25M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 86.9M |
| % held by insiders 1 | 10.90% |
| % held by institutions 1 | 77.97% |
| Shares short (12 May 2022) 4 | 20.3M |
| Short ratio (12 May 2022) 4 | 19 |
| Short % of float (12 May 2022) 4 | 29.65% |
| Short % of shares outstanding (12 May 2022) 4 | 19.11% |
| Shares short (prior month 13 Apr 2022) 4 | 16.56M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 29.41% |
| Operating margin (ttm) | 34.61% |
Management effectiveness
| Return on assets (ttm) | 16.12% |
| Return on equity (ttm) | 24.35% |
Income statement
| Revenue (ttm) | 380.23M |
| Revenue per share (ttm) | 3.37 |
| Quarterly revenue growth (yoy) | 17.90% |
| Gross profit (ttm) | 360.7M |
| EBITDA | 132.71M |
| Net income avi to common (ttm) | 111.84M |
| Diluted EPS (ttm) | 0.91 |
| Quarterly earnings growth (yoy) | -2.80% |
Balance sheet
| Total cash (mrq) | 345.53M |
| Total cash per share (mrq) | 3.25 |
| Total debt (mrq) | 2.82M |
| Total debt/equity (mrq) | 0.69 |
| Current ratio (mrq) | 6.78 |
| Book value per share (mrq) | 3.84 |
Cash flow statement
| Operating cash flow (ttm) | 177.72M |
| Levered free cash flow (ttm) | 139.04M |
© 2022 Yahoo. All rights reserved.
